文献速递临床试验与 GCP流行病学与生物统计

利用移动健康工具提高儿童COVID-19疫苗接种率(MoVeUp):一项随机对照试验的研究方案

Improving pediatric COVID-19 vaccine uptake using an mHealth tool (MoVeUp): study protocol for a randomized, controlled trial.
PubMed 文献 · Trials · 2022-10-28

本方案拟将至少有一名未接种COVID-19疫苗的合格儿童的监护家长/照护者随机分组,分别下载两种移动健康应用程序之一。干预组应用程序针对儿童COVID-19疫苗接种的物流和动机障碍,通过分支逻辑提供定制内容;对照组提供基于美国儿科学会和疾病控制与预防中心建议的儿童一般健康与感染预防信息。主要结局是儿童完成COVID-19疫苗接种系列的比例。

要点

  • 干预组应用程序针对儿童COVID-19疫苗接种的物流和动机障碍提供定制内容。
  • 主要结局为儿童完成COVID-19疫苗接种系列的比例。
  • 次要结局包括儿童接受至少1剂COVID-19疫苗的比例及家长/照护者改良WHO SAGE疫苗犹豫量表评分变化。

核心结论

  • 本方案旨在确定疫苗沟通移动健康应用程序对家长/照护者决定为其子女接种COVID-19疫苗的有效性。

研究设计与样本

  • 随机对照试验,将符合条件且尚未接种疫苗的儿童的监护家长/照护者随机分配至两种移动健康应用程序之一。
  • 干预组应用程序针对儿童COVID-19疫苗接种的物流和动机障碍,通过分支逻辑根据 locality、城乡程度、主要语言(英语/西班牙语)、种族/民族和儿童年龄提供定制内容。
  • 参与者将接受八次每周推送通知,随后两次每月推送通知(行动提示)。
  • 对照组应用程序提供基于美国儿科学会(AAP)和疾病控制与预防中心(CDC)建议的儿童一般健康与感染预防及缓解策略的推送通知和信息。

关键数值与推荐

  • 主要结局为儿童完成COVID-19疫苗接种系列的比例。
  • 次要结局包括儿童接受至少1剂COVID-19疫苗的比例。
  • 次要结局包括家长/照护者从基线至干预后即刻在针对COVID-19疫苗改编的改良WHO SAGE疫苗犹豫量表评分的变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Coronavirus disease 2019 (COVID-19) vaccines demonstrate excellent effectiveness against infection, severe disease, and death. However, pediatric COVID-19 vaccination rates lag among individuals from rural and other medically underserved communities. The research objective of the current protocol is to determine the effectiveness of a vaccine communication mobile health (mHealth) application (app) on parental decisions to vaccinate their children against COVID-19. METHODS: Custodial parents/caregivers with ≥ 1 child eligible for COVID-19 vaccination who have not yet received the vaccine will be randomized to download one of two mHealth apps. The intervention app will address logistical and motivational barriers to pediatric COVID-19 vaccination. Participants will receive eight weekly push notifications followed by two monthly push notifications (cues to action) regarding vaccinating their child. Through branching logic, users will access customized content based on their locality, degree of rurality-urbanicity, primary language (English/Spanish), race/ethnicity, and child's age to address COVID-19 vaccine knowledge and confidence gaps. The control app will provide push notifications and information on general pediatric health and infection prevention and mitigation strategies based on recommendations from the American Academy of Pediatrics (AAP) and the Centers for Disease Control and Prevention (CDC). The primary outcome is the proportion of children who complete COVID-19 vaccination series. Secondary outcomes include the proportion of children who receive ≥ 1 dose of COVID-19 vaccine and changes in parent/caregiver scores from baseline to immediately post-intervention on the modified WHO SAGE Vaccine Hesitancy Scale adapted for the COVID-19 vaccine. DISCUSSION: The COVID-19 pandemic inflicts disproportionate harm on individuals from underserved communities, including those in rural settings. Maximizing vaccine uptake in these communities will decrease infection rates, severe illness, and death. Given that most US families from these communities use smart phones, mHealth interventions hold the promise of broad uptake. Bundling multiple mHealth vaccine uptake interventions into a single app may maximize the impact of deploying such a tool to increase COVID-19 vaccination. The new knowledge to be gained from this study will directly inform future efforts to increase COVID-19 vaccination rates across diverse settings and provide an evidentiary base for app-based vaccine communication tools that can be adapted to future vaccine-deployment efforts. CLINICAL TRIALS REGISTRATION: ClinicalTrials.gov NCT05386355 . Registered on May 23, 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. McCulloh RJ, Darden PM, Snowden J, et al. Improving pediatric COVID-19 vaccine uptake using an mHealth tool (MoVeUp): study protocol for a randomized, controlled trial. Trials. 2022. PMID: 36307830. doi:10.1186/s13063-022-06819-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。